iShares MSCI Japan ETF news

The ETF is mentioned only as an underlying asset being tokenized. The listing is neutral as it represents expanded distribution channels rather than direct fund performance or strategy changes.

Presented as a competitive alternative with lower expense ratio (0.49%) compared to OPPJ and the largest asset base ($23.3 billion) among the three compared funds, offering better value and stability.

Faces headwinds from higher discount rates reducing present value of earnings, potential yen strength pressuring exporters' competitiveness, and reduced corporate investment from higher borrowing costs, though some offset from banking sector gains.

Mentioned as an alternative Japan-focused ETF with the largest assets ($23.48 billion) and comparable expense ratio (0.49%), but no performance metrics provided for evaluation.

Highlighted as another competitive alternative with lower expense ratio (0.49% vs 0.58%) and the largest asset base ($24.3 billion) among the three compared funds, offering better liquidity and lower costs.

Returned approximately 19.1% year-to-date, showing steady performance in Japanese markets.

EWJ is highlighted as another attractive alternative with low expenses (0.49%) and the largest asset base ($23.19 billion) among the compared funds, offering traditional market cap-weighted exposure at a lower cost than FJP.

Unhedged large-cap exposure positioned to benefit from accelerated BOJ rate hikes and sustained yen appreciation; up 20.1% year-to-date with strong liquidity and $23.34B in assets.

Stronger yen reduces the value of overseas earnings for Japanese exporters, suppressing gains in Japan equity ETFs despite recent modest gains.

The fund is recommended as a way to gain broad exposure to the Japanese market, which is outperforming with 19% year-to-date gains and benefits from strong export growth and economic expansion.

Recommended as a single-country alternative with different growth drivers, attracting nearly $4B in inflows year-to-date

CAPE ratio of 26.4 is below its 20-year average, with forecasted 6.2% annualized returns, offering better value than U.S. equities.